Ruxolitinib as GVHD Prophylaxis in AA Patients

Clinical trial NCT05914714 · UNKNOWN

Trial details

NCT number: NCT05914714
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA

Start date: 2023-07-01
Primary completion: 2025-05-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.